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ABSTRACT This study was conducted to assess the
effect of dietary supplementation of Muramidase 007 to
broiler chickens on gastrointestinal functionality, eval-
uating growth performance, apparent ileal digestibility,
intestinal histomorphology, vitamin A in plasma and
cecal microbiota. A total of 480 one-day male chicks
(Ross 308) were distributed in 16 pens allocated in
2 experimental diets: the control diet (CTR) without
feed enzymes, coccidiostat or growth promoters, and
the experimental diet (MUR): CTR supplemented with
35,000 units (LSU(F))/kg of the Muramidase 007. Di-
gesta and tissue samples were obtained on days 9 and 36
of the study. A lower feed conversion ratio was observed
in the MUR treatment. Apparent ileal digestibility of
DM, organic matter and energy were improved by Mu-
ramidase 007. It was also observed that MUR improved
digestibility of total fatty acids, mono-unsaturated fatty
acids and poly-unsaturated fatty acids, and content
of vitamin A in plasma at day 9 (P < 0.05). Histo-
morphological analysis of jejunum samples revealed no
differences in the villus height or crypt depth; but a
higher number of goblet cells and intraepithelial lym-
phocytes at day 36 with MUR. No differences were
observed in plate counts of enterobacteria or Lacto-
bacillus along the gastrointestinal tract, neither on the
cecal short-chain fatty acids. An statistical trend was
observed for reduction of cecal clostridia at day 9 for
MUR. Analysis of cecal microbiota structure by 16S
rRNA gene sequencing revealed relevant changes corre-
lated to age. At day 9, broilers receiving MUR showed
decreased alpha diversity compared to CTR that was
not detected at day 36. Changes in specific taxonomic
groups with an increase in Lactobacillus genus were
identified. In conclusion, evaluation of the variables in
this study indicates that dietary Muramidase 007 con-
tributes to improve feed conversation ratio and gas-
trointestinal function in broiler chickens. Effects could
have been mediated by slight shifts observed in the
intestinal microbiota. More studies are guaranteed to
fully understand the mechanisms involved.
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INTRODUCTION
A fast growth rate and high feed efficiency are the
2 main targets in modern poultry production. For op-
timum performance of birds, important factors affect-
ing gastrointestinal health like genetic potential of the
birds, quality of the diets, environmental conditions,
and disease outbreaks, should be taken into consid-
eration (Yegani and Korver, 2008). Actually, in the
modern poultry industry, multi-environment selection
is employed by the breeding companies (Neeteson, 2010;
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Kapell et al., 2012). In addition, an effective functional-
ity of the gastrointestinal tract (GI) is very important
in determining animal performance. Optimal GI func-
tionality has been recently defined as a steady state
where the microbiome and the intestinal tract (host)
exist in symbiotic equilibrium, allowing the mainte-
nance of key physiological functions resulting in im-
proved health and welfare and performance (Celi et al.,
2017). Among all components involved in GI functional-
ity and health, the composition and metabolic activity
of the GI tract microbiota have a significant impact on
the health of the host due to their influence on nutri-
ent absorption, intestinal physiology, immune response,
and consequently, resistance to pathogen colonization
(Apajalahti et al., 1998; Lu et al., 2003; Santos et al.,
2008).
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While probiotics, essential oils, organic acids, or pre-
biotics are used to help stabilizing the gut microbiota,
little attention has been paid so far on the massive
turnover and dead of the bacterial populations resulting
in high amounts of bacterial cell wall fragments, con-
taining peptidoglycans (PGN), that take place in the
GI tract (Johnson et al., 2013). PGNs are the mayor
structural components of the cell wall, uniquely found
in bacteria, and considered as conserved products of
bacterial metabolism and activity modulators in the GI
tract (Humann and Lenz, 2009).
Muramidase (EC 3.2.1.17), also known as lysozyme
or N-acetylmuramidase, belongs to the family of glyco-
syl hydrolytic enzymes. Muramidase cleaves the β-1,4-
glycosidic linkages between N-acetylmuramic acid and
N-acetyl glucosamine, the basic elements in the carbo-
hydrate backbone of PGN from bacterial cell walls. The
most studied muramidase is the one abundantly found
in hen egg white, however, many muramidases are nat-
urally found in a great variety of animal secretions,
plants, or micro-organisms. Muramidases are ubiqui-
tous and occur naturally in the GI tract of animals
(Sahoo et al., 2012).
Studies with nursery pig using diets supplemented
with muramidase (isolated from hen egg white) re-
sulted in ameliorated growth performance probably
due to improvements on histomorphology of small in-
testine (Oliver and Wells, 2013, 2015). Contributing
to better gut integrity as well as stronger nonspe-
cific immune response could also explain the perfor-
mance improvements (Oliver and Wells, 2015; Long
et al., 2016). Recently, it was demonstrated that di-
etary supplementation of a novel microbial murami-
dase (Muramidase 007) in broiler diets improved the
performance variables, increased the number of lac-
tobacilli without disturbing the rest of the func-
tional microbiota in the caecum of broilers, while
proven safe for the chickens in a tolerance study
(Lichtenberg et al., 2017). Moreover (Goodarzi Boroo-
jeni et al., 2019) supplementing increasing dosis of this
muramidase reported improvements in feed conversion
ratio (FCR) and apparent ileal digestibility (AID) of
nutrients.
The present study aimed to evaluate the impact of
dietary supplementation of Muramidase 007 on the GI
functionality of broiler chickens by measuring AID of
nutrients, intestinal histomorphology, vitamin A con-
tent in plasma, microbial ecosystem and metabolism,
and animal performance variables.
MATERIALS AND METHODS
The in vivo experimental procedure of this study was
performed at the Experimental Unit of the Universi-
tat Autònoma de Barcelona (UAB) and received prior
approval from the Animal and Human Experimental
Ethical Committee of this Institution. The treatment,
management, housing, husbandry and slaughtering
conditions strictly conformed to European Union
Guidelines (Directive 2010/63/EU).
Muramidase
The novel muramidase used in this study was selected
through a discovery program. The gene coding for this
muramidase (denominated Muramidase 007) from the
fungus Acremonium alcalophilum (strain 114.92) was
expressed in an industrial production host, produced
in enough amounts and characterized as described by
Lichtenberg et al. (2017). This product was produced
by Novozymes A/S (Bagsvaerd, Denmark).
Location and Housing
Animals were housed in one single room with 16
floor pens (8 pens (1.5 m × 1 m) at each side of
the room). The environmental conditions (lighting pro-
gram, temperature, relative humidity and ventilation
rates) were controlled accordingly to the Ross broiler
management guidelines. Animals disposed of nipple
drinkers (3 drinkers/pen) and manual pan feeders
(1 pan/pen). Litter material was wood shavings.
Animals and Diets
A total of 480 one-day-old male broiler chickens (Ross
308), were obtained from a local hatchery (Pondex
SAU, Lleida, Spain), already vaccinated in ovo against
Gumboro and Marek diseases. Additionally, chicks were
vaccinated against coccidiosis (coarse spray; Hypracox,
Amer, Spain) and infectious bronchitis (fine spray) at
day 1 after hatching. The birds were individually wing-
tagged, weighted and randomly distributed in 16 pens
(30 chicks per pen).
Each pen was allocated to one of 2 experimental
treatments: A control diet (CTR) or CTR diet sup-
plemented with Muramidase 007 (MUR) at 35,000 mu-
ramidase units (LSU(F))/kg. During the experimental
period the birds received a feeding program of 2 phases:
a starter diet from 0 to 21 d (in crumble form) and a
grower diet from 21 to 36 d (in pellet form). Diets were
formulated to meet or exceed FEDNA (2008) require-
ments, as it figures in Table 1. Basal diets did not con-
tain any feed enzymes (other than Muramidase 007 in
the experimental diet), coccidiostats, veterinary antibi-
otics or any other growth promoters. In addition, tita-
nium dioxide (TiO2) was added as indigestible marker
at 0.5%.
Experimental Procedures
Individual weight of the animals and feed residuals
(by pen) were registered at days 0 (arrival), 9 (first
sampling), 21 (change of diet), and 36 (final day-second
sampling) to monitor individual body weight (BW) as
well as the feed intake along the study. From these
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Table 1. Ingredient and nutrient composition of basal diets.
Ingredients (%, as-fed basis) Starter Grower




Soybean oil 4.86 -
Dicalcium phosphate 1.79 1.47
Fat 5 FYSFEED1 - 5.54
Calcium carbonate 0.92 0.80
Sodium chloride 0.40 0.36
Mineral-vitamin premix2 0.30 0.30
DL-methionine 0.27 0.23
L-lysine 0.17 0.19
Choline chloride 0.04 -
L-threonine 0.04 0.05
Ethoxyquin 66%3 0.02 0.02
TiO2 0.50 0.50
Carophyll Yellow4 0.006 0.006
Calculated nutrients (%, DM basis)
Calcium 0.95 0.80
Digestible phosphorus 0.45 0.38
Digestible lysine 1.20 1.02
Digestible methionine + cysteine 0.87 0.76
Digestible threonine 0.76 0.66
Analyzed nutrients (%, DM basis) CTR5 MUR6 CTR5 MUR6
Dry Matter 91.49 91.26 90.27 90.35
Crude protein 24.10 23.48 20.07 20.23
Crude fat 6.60 6.36 7.08 7.07
Crude fiber 3.02 3.58 2.87 2.91
Ash 6.03 6.17 5.56 5.42
Gross energy (kcal/kg) 4157 4103 4096 4090
Muramidase activity (LSU(F)/kg) 1089 33,025 962 28,879
1Fat 5 FYSFEED (SYSFEED, Granollers, Spain) is a commercial
source of animal fat obtained by mechanical pressing after cooking of
slaughterhouse by-products coming from animals declared fit from hu-
man consumption before and after slaughter.
2One kg premix contains vitamin A (all-trans retinol/retynil
acetate/retynil palmitate/β-carotene): 3333,334 IU; vitamin D3:
1600,000 IU; vitamin E (dl-α-tocopheryl acetate/dl-α-tocopherol/d-α-
tocopherol): 15,000 IU; vitamin K3: 1,000 mg; vitamin B1: 1,000 mg;
vitamin B2: 3,000 mg; vitamin B6: 1,500 mg: vitamin B12: 13.3 mg; folic
acid: 600 mg; biotin: 50 mg; calcium pantothenate: 5,500 mg; nicotinic
acid: 17,000 mg; Mn: 30,000 mg; Zn: 22,000 mg; I: 400 mg; Fe: 18,000 mg;
Cu: 4,000 mg; Se: 60 mg; ethoxyquin: 1,333 mg; fumaric acid: 25,0000 mg;
and malic acid: 20,000 mg.
3Ethoxyquin antioxidant produced by ITPSA (Barcelona, Spain).
4Carophyl yellow (10% Apo-ester; DSM Nutritional Products Ltd,
Kaiseraugst, Switzerland).
5CTR: Control diet.
6MUR: Muramidase supplemented diet at 35,000 LSU (F)/kg.
values the average daily feed intake (ADFI), average
daily weight gain (ADG), and the FCR were calculated.
At 9 d of live, 21 birds per cage were randomly se-
lected and euthanized by decapitation, and represen-
tative samples of mid-jejunum tissue, ileal digesta and
blood, were taken. At 35 d of age, the remaining birds
were euthanized, and the same procedure was repeated.
Jejunal tissue was collected from 1 bird per pen for
histological analysis. Content from different intestinal
segments: crop, ileum and cecum were collected; indi-
vidually from 2 birds per pen, 1 for classical micro-
biology and the other for microbiota (1 cecum) and
short-chain fatty acids (SCFA) analysis (other ceca).
Moreover, representative sample of terminal ileum con-
tent of each cage was taken (21 birds at 9 d; 7 birds
at 36 d) for AID analyses. Digesta was homogenized,
kept frozen at -20°C, freeze-dried, grounded, and kept
at 5°C until analyzed.
Pooled sample of blood was sampled via venipuncture
(2 or 3 animals on 9 d and individual bird on 36 d
from each pen) and was taken in heparinized tubes for
vitamin A analyses.
Analytical Methods
AID AID was calculated using the index marker for a
100% recovery. Analytical determinations of feeds and
digesta were performed accordingly to the Association
of Official Agricultural Chemists (AOAC) International
methods (2005): dry matter (Method 934.01) by desic-
cating the sample in an air-forced oven at 103°C for
24 h. Organic matter (OM) content was gravimetri-
cally measured by placing samples in a muffle furnace at
550°C for 4 h, (ash, Method 942.05), crude fat (Method
2003.05 for feed and with previous acid hydrolysis, fol-
lowing method 954.02 of the AOAC for excreta) and
gross energy content (IKA-Kalorimeter system C4000,
Staufen, Germany). The fatty acid (FA) content of the
feed and digestive content was determined according to
the method of Sukhija and Palmquist (1988). This an-
alytic procedure consists of a direct transesterification
(the lipid extraction and FA methylation is achieved in
only one step). Samples were incubated at 70°C with
methanolic hydrochloric acid (a mixture of methanol
and acetyl chloride) for the methylation. After the
extraction and methylation potassium carbonate and
toluene were added to separate the organic layer. Non-
adecanoic acid (C19; Sigma-Aldrich Chemical Co., St.
Louis, MO) was used as internal standard. The final
extract was injected in a gas chromatograph (HP6890,
Agilent Technologies, Waldbronn, Germany) following
the method conditions previously described by Corti-
nas et al. (2004). FAs were identified by matching their
retention times with those of their relative standards
(Supelco 37 component FAME Mix, Sigma-Aldrich Co.,
St. Louis, MO) and quantified by internal normaliza-
tion. Nonadecanoic acid was used for the calibration
curves and quantification of FA. Total FAs (TFA) con-
tent was calculated as the sum of individual FAs. Ni-
trogen was analyzed by the DUMAS method. Analysis
of Ti of the Titanium dioxide (TiO2) marker was per-
formed by atomic absorption spectroscopy (AAS). The
AID of dry matter (DM), OM, nitrogen (N), FA, and






Where [Ntr]M is the nutrient content in the ileal di-
gesta, [Ntr]D is the nutrient content in the diet, [Ti]M
is the concentration of Ti in the ileal digesta, and [Ti]D
is the concentration of Ti in the diet.
Vitamin A Plasma proteins were precipitated with
ethanol. Retinol was extracted from the aqueous
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suspension with n-hexane/butylated hydroxytoluene
solution. After centrifugation, an aliquot of the organic
phase was dried, re-dissolved in solvent solution and in-
jected into a reversed-phase (C18) HPLC system. The
detection was performed with a fluorescence detector.
Classical Microbiology and Jejunal Histomor-
phology Colony forming units (cfu) count of enter-
obacteria, lactobacilli and clostridia, in the content
of crop, ileum and cecum was performed by selec-
tive growth medium. Enterobacteria were counted af-
ter 24 to 48 h of incubation in MacConkey agar. Lac-
tic acid bacteria were determined in MRS agar and
clostridia in SPS Agar used for isolation and enumera-
tion of sulphite-reducing clostridia. To evaluate possible
changes in the microbiota metabolism, the concentra-
tion of SCFA was analyzed in cecal samples by gas chro-
matography following the method of Jouany (1982).
Histological analysis was performed in tissue sam-
ples from jejunum fixed by immersion in 10% forma-
lin, paraffin-embedded, and sections stained with hema-
toxylin/eosin. Measurements analyzed included villus
height (μm), crypt depth (μm), villus: crypt ratio, vil-
lus width (μm), villus surface (mm2), intraepithelial
lymphocytes (IEL) (number cells/100 μm), goblet cells
number (GC) (cells/100 μm), and number of mitoses
(cells/100 μm).
Molecular Microbiology DNA from cecal samples
was extracted using the QIAamp DNA Stool Mini Kit
(Qiagen, Toronto, Canada) according to the manufac-
turer’s instructions. The global structure, dynamics and
functionality of the cecal microbial populations was an-
alyzed by high throughput sequencing, targeting V3-V4
region of 16S rRNA, using the kit MiSeq® Reagent Kit
v2 (500 cycle) (MiSeq, Illumina, San Diego, CA).
Primers used in the construction of libraries were the





Sequence reads of 16S rRNA gene generated from
MiSeq Illumina® system were processed on QIIME
v.1.9.1. The quality filter of already demultiplexed se-
quences was performed at a maximum unacceptable
Phred quality score of Q20. Resulting reads were clus-
tered to operational taxonomic unit (OTU) using uclust
algorithm with 97% sequence similarity and subsam-
pling pick open reference method (Rideout et al., 2014)
at 10% of sequences subsampled. Representative se-
quences were assigned to taxonomy against bacterial
16S GreenGenes v.13.8 reference database at a 90%
confidence threshold and sequence alignment and phy-
logenetic tree building were obtained through uclust
and FastTree. Thereafter, chimeric sequences were re-
moved with ChimeraSlayer with default settings and
further quality filtering consisted in removing single-
tons and OTUs with relative abundance across all sam-
ples below 0.005% as recommended by Bokulich et al.
(2013).
Statistical Analysis
The results are expressed as means with their stan-
dard errors unless otherwise stated. Data were analyzed
with ANOVA using the GLM procedure of SAS and the
following statistical model:
Yij = μ + Bi + εi
Where Yij is the dependent variable, µ is the overall
mean, Bi is the additive effect, and ɛi is the residual
error effect.
When frequencies were analyzed, the Fisher’s exact
test was used. For the microbiological data, the plate
counts values were log-transformed. All statistical anal-
yses were performed using the Statistical Analysis Soft-
ware SAS version 9.2 (SAS Institute Inc., Cary, NC).
The pen was considered as the experimental unit for all
the variables analyzed except for classical microbiology
and histology. In those analyses, the bird was consid-
ered the unit since only 1 bird per pen was sampled.
The α level used for the determination of significance
for all the analysis was P = 0.05. The statistical trend
was also considered for P-values > 0.05 and < 0.10.
Biostatistics of quality filtered sequences of the 16S
rRNA gene were performed using an open source soft-
ware (R v.3.4.0; R Core Team, 2013) after importing
the OTU table to R using the phyloseq package. Di-
versity and ordination analysis (non-multidimensional
scaling, NMDS) were performed using the vegan pack-
age at OTU level. Richness and alpha diversity were cal-
culated with raw counts while beta diversity and ordi-
nation analysis were obtained with relative abundances.
Alpha diversity consisted of calculation of three related
indexes: Shannon, Simpson and Simpson inverse. For
beta diversity, betadiver() function based on Whittaker
index was used. To compare any differential effects from
treatments, an ANOVA analysis was performed for al-
pha and beta diversities. Bray-curtis distance matrix
was calculated from the dissimilarities between pairs
of samples and the relative position of each sample
was projected and analyzed in the NMDS plot. Finally,
read counts were normalized with the metagenomeSeq
package, that uses a cumulative-sum scaling where raw
counts are divided by the cumulative sum counts into
a particular quantile, by which differential abundance
analysis under a zero-inflated Gaussian model could
be performed. To achieve that, taxa were aggregated
at Phylum and Genus level and expressed as log10
(n + 1).
RESULTS
The trial was successfully carried out and animals
showed good health along the whole study. Mortality
was very low along the trial being 0.83% and 1.25% for
CTR and MUR, respectively with no difference between
treatments.
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Table 2. Performance of broiler chickens fed a control diet (CTR)
or the same diet supplemented with Muramidase 007 (MUR)
during the starter and grower periods.
Treatments1
Variables CTR2 MUR3 SEM P-value
BW (g)
0 d 42 42 0.1 0.438
9 d 259 259 2.7 1.000
21 d 1005 1030 11.1 0.134
36 d 2787 2844 27.9 0.172
ADG (g/d)
0 to 21 d 45.7 47.1 0.61 0.137
21 to 36 d 118.8 119.4 1.60 0.820
0 to 36 d 76.2 77.1 0.75 0.415
ADFI (g/d)
0 to 21 d 63.9 62.1 1.09 0.277
21 to 36 d 172.0 165.3 3.22 0.162
0 to 36 d 108.9 105.1 1.34 0.063
FCR4 (g feed:g BW gain)
0 to 21 d 1.40 1.32 0.04 0.128
21 to 36 d 1.45 1.39 0.03 0.207
0 to 36 d 1.43 1.36 0.02 0.045
1Data are means for 8 replicate pens with 30 birds from days 0 to 9
and 9 birds from days 9 to 36.
2CTR: Control diet.
3MUR: Muramidase supplemented at 35,000 LSU (F)/kg.
4Feed Conversion Ratio.
Table 2 shows the evolution of BW, ADG, ADFI,
and FCR along the study. There were no differences
between treatments in the BW or in the ADG although
final BW showed numerical values (P = 0.172) with the
addition of MUR. Moreover, animals receiving MUR in
the diet showed higher ADFI (P = 0.060) and higher
FCR (P = 0.050) when all the experimental period was
considered.
The AID (%) of E, DM, OM, N, TFA, saturated fatty
acids (SFA), mono-unsaturated fatty acids, (MUFA),
and poly-unsaturated fatty acids (PUFA) estimated us-
ing TiO2 as digestibility marker are shown in Table 3.
The inclusion of MUR in the diets increased the di-
gestibility of E at day 36 (P < 0.001) and shown nu-
merical higher values at day 9 (P = 0.120). The in-
creased amount of digested energy could be the result
of the observed increase in the DM and OM digestibil-
ity at day 36 (more than 4 percent; P < 0.001). Di-
gestibility of N showed an increase of more than 2%
at day 36, although differences did not reach statisti-
cal significance (P = 0.095). Digestibility of TFA was
higher with MUR but the effects were only evidenced
at day 9 (P = 0.049). This increase in the digestibil-
ity with the inclusion of MUR in the diets was seen
in all studied fractions: SFA (P = 0.08), MUFA and
PUFA.
Regarding plasma vitamin A concentration, it was
found an increase in total retinol at day 9 with the sup-
plementation of MUR (MUR: 615.6 ng/mL vs. CTR:
521.4 ng/mL; P = 0.040). At day 36, both diets showed
higher values, without differences (CTR: 775.5 ng/mL
and MUR: 740.9 ng/mL; P = 0.556).
Histomorphological observations in jejunum are
shown in Table 4. None of the experimental diets
modified the villus height or crypt depth, neither the
villus/crypt ratio. Increases (P < 0.05) were detected
with the MUR treatment at day 36 in IEL and GC,
regardless if they were expressed in absolute or relative
terms.
Regarding possible changes induced by the experi-
mental diets on cecal profile and concentration of to-
tal SCFA, no statistically significant differences among
treatments on the profile, concentration of SCFA or
their molar percentage at any of the sampling days were
detected (data not shown).
Regarding possible effects on microbiota, neither lac-
tobacilli nor enterobacteria (log cfu/g fresh matter)
were modified by the experimental treatments in any
gastrointestinal section and any sampling day (Table 5).
For clostridia, as plate counts were in some animals be-
low detection level of the method, a frequency anal-
ysis was performed (Table 6). By this mean, it could
be seen that MUR tended to decrease the number of
animals with detectable clostridia in cecum at day 9
(P = 0.060).
The analysis of the cecal microbiota profile by se-
quencing of the V3-V4 region of the 16S rRNA gene
revealed relevant structural changes related to the de-
velopment of the cecal microbiota with age. Figure 1
shows the community structure based on Bray-Curtis
distance matrix with OTUs. A clear impact of the age
was observed on cecal microbiota structure being clus-
tered closer microbial structures of day 9 than those
of day 36, coincident with numerical higher beta di-
versity value for the later (data not shown). Interest-
ingly, at day 36 a group of animals from both treat-
ments clustered separately to the rest (4 from CTR
treatment and 6 from MUR treatment) with a pro-
file closer to those animals of day 9, suggesting that
these animals had not evolved to a mature ecosystem.
Nonetheless, animals of day 9 presented higher rich-
ness range (600 to 1000 OTU) than those from day
36 (250 to 800 OTU), despite similar number of reads
between both ages. Phyla distribution was similar be-
tween ages, being Firmicutes (60 and 55% for 9 and
36 d, respectively) and Bacteroidetes (26 and 35% for 9
and 36 d, respectively) the main phyla registered. When
analyzing differences in relative abundance of genera
(Tables 7 and 8), it was registered a relevant increase in
the percentage of Bacteroides with age (from 7 to 29%).
Regarding to changes promoted by experimental diets,
animals receiving MUR showed a decrease in alpha di-
versity (Simpson Index (P = 0.052); Shannon index
(P = 0.091); Simpson inverse index (P = 0.001)) but no
differences were detected in beta diversity. At day 36 no
changes were detected in alpha or beta diversity. When
differences in abundance of taxa promoted by diets were
analyzed, no changes were seen in phyla at day 9, nor
at day 36. Only minor changes were found in genera
at day 36 (Table 8) with an increase in Lactobacillus
(3.28 ± 2.319% vs. 4.90 ± 1.087%) and cc-115 (0.01
± 0.003% vs 0.15 ± 0.046%) genera when analyzed as
normalized counts (P < 0.05).
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Table 3. Apparent ileal digestibility (%) of energy and nutrients in broiler chickens fed a
control diet (CTR) or the same diet supplemented with Muramidase 007 (MUR) during the
starter and grower periods.
Treatments2
Apparent ileal digest. (%)1 Day CTR3 MUR4 SEM P-value
Energy 9 71.2 72.4 0.52 0.123
36 71.8 75.6 0.50 <0.001
Dry Matter 9 68.4 69.6 0.45 0.085
36 68.1 72.3 0.49 <0.001
Organic Matter 9 69.7 70.9 0.44 0.077
36 69.8 74.0 0.47 <0.001
Nitrogen 9 82.2 82.9 0.40 0.264
36 75.2 77.5 0.91 0.095
Total fatty acids (TFA) 9 86.5 89.1 0.85 0.049
36 88.9 90.3 0.98 0.324
Saturated fatty acids (SFA) 9 61.5 67.6 2.29 0.080
36 83.9 85.1 1.37 0.530
Mono-unsaturated fatty acids (MUFA) 9 82.4 86.3 1.29 0.048
36 91.3 92.5 0.96 0.407
Poly-unsaturated fatty acids (PUFA) 9 95.6 96.7 0.26 0.012
36 90.6 92.2 0.85 0.208
1Apparent ileal digestibility was estimated using TiO2 as digestibility marker.
2Data are means for 8 replicate pens with 19 pooled birds from days 9 and 7 pooled birds from
day 36.
3CTR: Control diet.
4MUR: Muramidase supplemented at 35,000 LSU (F)/kg.
Table 4. Histomorphometry of jejunum in broiler chickens fed a
control diet (CTR) or the same diet supplemented with Murami-
dase 007 (MUR) during the starter and grower periods.
Treatment1
Variables Day CTR2 MUR3 SEM P-value
Villus height (µm) 9 442.3 444.1 15.60 0.936
36 1027.8 996.3 38.50 0.572
Crypt depth (µm) 9 147.5 157.6 6.67 0.303
36 185.3 170.5 6.08 0.108
Villus:crypt ratio (µm: µm) 9 3.1 2.9 0.13 0.288
36 5.7 6.1 0.23 0.258
IEL4 (cells) 9 15.4 18.0 2.59 0.495
36 46.0 59.6 2.49 0.002
GC5 (cells) 9 22.1 23.6 1.61 0.500
36 57.6 72.7 2.96 0.003
1n = 8 animals.
2CTR: Control diet.
3MUR: Muramidase supplemented at 35,000 LSU (F)/kg.
4IEL: intraepithelial lymphocytes.
5GC: goblet cells regardless they were expressed in absolute or relative
terms.
DISCUSSION
Effect on Growth Performance and AID
In the present study, the inclusion of the Murami-
dase 007 in broiler chicken diets, throughout the whole
growing period, had a relevant impact on their FCR at
the end of the trial. FCR improved from 1.43 to 1.36 g
feed: g BW gain (P = 0.045) at day 36. These data
agree with those obtained by Lichtenberg et al. (2017)
and Goodarzi Boroojeni et al. (2019), who reported a
significant improvement in BW gain and FCR when
Muramidase 007 was included at different dose lev-
Table 5. Plate counts (log cfu/g fresh matter) for different micro-
bial groups in crop, ileum, and cecum digesta in broiler chickens
fed a control diet (CTR) or the same diet supplemented with
Muramidase 007 (MUR) during the starter and grower periods.
Treatment1
Section Day Microbial group CTR2 MUR3 SEM P-value
Crop 9 Lactobacillus 8.1 7.9 0.75 0.799
Enterobacteria 6.5 6.9 1.08 0.810
36 Lactobacillus 7.5 7.6 0.35 0.805
Enterobacteria 4.5 5.3 0.37 0.176
Ileum 9 Lactobacillus 8.1 8.3 0.60 0.885
Enterobacteria 5.3 5.8 0.75 0.645
36 Lactobacillus 9.5 8.8 0.40 0.201
Enterobacteria 7.1 6.4 0.49 0.296
Cecum 9 Lactobacillus 11.0 9.9 0.62 0.219
Enterobacteria 11.3 11.4 0.37 0.815
36 Lactobacillus 10.5 11.3 0.42 0.224
Enterobacteria 11.3 11.1 0.38 0.821
1n = 8 animals.
2CTR: Control diet.
3MUR: Muramidase supplemented at 35,000 LSU (F)/kg.
els. Other studies have also reported similar effects on
growth performance when other muramidases, from dif-
ferent origins, were included on broiler diets. Humphrey
et al. (2002) found that chickens fed a conventional diet
containing 10% modified rice expressing lysozyme had
an improved feed efficiency (P = 0.01). Liu et al. (2010)
reported that supplemental hen egg white lysozyme
(HEWL) significantly improved FCR and tended to in-
crease weight gain (P = 0.082). Abdel-Latif et al. (2017)
also reported that BW gain and FCR were significantly
improved when HEWL was included in poultry diets
(P < 0.05). However, Gong et al. (2016) reported no
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Table 6. Number of animals with detectable number of clostridia
along the gastrointestinal tract (minimum level of detection 10
cfu/g). Broiler chickens were fed a control diet (CTR) or the
same diet supplemented with Muramidase 007 (MUR) during
the starter and grower periods.
Treatment1
Clostridium (+) Day CTR2 MUR3 P-value
Crop 9 4/8 (4.4) 5/8 (5.3) 0.343
36 4/8 (4.4) 6/8 (6.2) 0.245
Ileum 9 7/8 (7.1) 3/8 (3.5) 0.056
36 6/8 (6.2) 6/8 (6.2) 0.431
Cecum 9 7/8 (7.1) 5/8 (5.3) 0.246
36 5/8 (5.3) 4/8 (4.4) 0.343
1n = 8 animals.
2CTR: Control diet.
3MUR: Muramidase supplemented at 35,000 LSU (F)/kg.
effect found on growth variables by the inclusion of
HEWL on broiler diets (P > 0.05).
This improvement observed in FCR is consistent with
the improvement reported in ileal apparent digestibil-
ity of energy, DM, and OM that also was reported by
Goodarzi Boroojeni et al. (2019) for this muramidase.
It can be hypothesized that an improved digestibility
of nutrients could be due to a better intestinal absorp-
tion (Noy and Skylan, 1995). However, attending to the
histomorphological effect of the diets, we were not able
to show changes in the height of jejunal villi or crypt
depth despite Goodarzi Boroojeni et al. (2019) were
able to find an increase in ileal villus length to crypt
depth ratio with this same muramidase. However, at
the end of the study, we observed an increment on the
number of GC in the jejunum of chickens fed the MUR
diet. Mucus constitutes a protective barrier against
Figure 1. Community structure based on Bray-Curtis distance matrix. Non-metric multidimensional scaling (NMDS) of operational taxonomic
unit (OTU) relative abundances in broiler chickens fed a control diet (CTR) or the same diet supplemented with Muramidase 007 (MUR) during
the starter and grower periods. Data are clustered by the age of the animal (sampling days at 9 and 36 d of life) and the experimental diets (CTR
diet and MUR diet). Black: CTR day 9; blue: MUR day 9; white; CTR day 36; and green: MUR day 36.
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Table 7. Microbiota composition at the genus level for the 15
most abundant genera in cecal digesta of broilers of 9 d of live
receiving control diet (CTR) or the same diet supplemented with
Muramidase (MUR). Results are expressed as relative abundance




Bacteroides 7.45 ± 0.601 5.89 ± 0.572
Ruminococcus 3.98 ± 0.465 7.48 ± 2.114
Oscillospira 4.13 ± 0.420 4.82 ± 0.491
Prevotella 4.34 ± 0.350 3.35 ± 0.340
Lactobacillus 3.28 ± 1.267 2.88 ± 0.887
Parabacteroides 3.23 ± 0.266 2.58 ± 0.259
Akkermansia 1.99 ± 0.974 1.07 ± 0.197
Ruminococcus 1.54 ± 0.207 1.19 ± 0.151
Coprococcus 1.44 ± 0.172 1.94 ± 0.608
Anaerotruncus 0.58 ± 0.206 0.60 ± 0.236
Enhydrobacter 0.72 ± 0.071 0.59 ± 0.075
Clostridium 0.40 ± 0.173 0.30 ± 0.063
Bifidobacterium 0.72 ± 0.067 0.51 ± 0.061
Dorea 0.45 ± 0.101 0.41 ± 0.094
Actinobacillus 0.57 ± 0.058 0.45 ± 0.057
1n = 21 for CTR, and n = 24 for MUR.
2CTR: Control diet.
3MUR: Muramidase supplemented at 35,000 LSU (F)/kg.
Table 8. Microbiota composition at the genus level for the 15
most abundant genera in cecal digesta of broilers of 36 d of live
receiving control diet (CTR) or the same diet supplemented with
Muramidase 007 (MUR). Results are expressed as relative abun-
dance (% ± SE) by diet.
Treatment1
Genus CTR2 MUR3
Bacteroides 32.67 ± 2.253 24.41 ± 1.801
Oscillospira 4.21 ± 0.409 4.90 ± 0.316
Lactobacillus 3.28b ± 2.319 4.90a ± 1.087
Akkermansia 3.83 ± 0.714 2.08 ± 0.370
Sutterella 2.22 ± 0.290 1.96 ± 0.323
Ruminococcus 1.46 ± 0.210 2.64 ± 0.396
Megamonas 0.92 ± 0.574 0.69 ± 0.261
Ruminococcus 1.28 ± 0.126 1.26 ± 0.096
Prevotella 0.89 ± 0.332 1.47 ± 0.430
Coprococcus 0.64 ± 0.113 1.67 ± 0.408
Parabacteroides 0.65 ± 0.242 0.99 ± 0.275
Anaerotruncus 0.73 ± 0.261 0.41 ± 0.116
Blautia 0.18 ± 0.026 0.44 ± 0.162
Bifidobacterium 0.15 ± 0.060 0.21 ± 0.061
Dorea 0.20 ± 0.035 0.16 ± 0.018
1n = 24 for CTR and n = 25 for MUR.
2CTR: Control diet.
3MUR: Muramidase supplemented at 35,000 LSU (F)/kg.
a,bMeans within a row lacking a common superscript differ (P < 0.05).
microorganisms, physical and chemical attacks, and has
the role of lubrication of the digestive tract (Deplancke
and Gaskins, 2001) it is considered as a major compo-
nent of innate immunity. We could therefore hypoth-
esize that the increase observed in GC, and presum-
ably in the mucus layer density, could have facilitated
a better nutrient digestion and absorption, explaining
the improved efficiency of feed utilization. However it
is truth that the role of intestinal mucus is complex
and still unknown, and that a higher numbers of goblet
cells not necessarily means a higher amount of mucus.
Mucus layer is known to provide a niche for bacterial
colonization offering attachment site and carbon source
for resident bacteria. Both, bacteria and the host can in-
fluence the composition for the mucus layer, and mucus
can turn in a way to the host to modulate its indigenous
microbiota although mucus-derived components could
also offer cues for adaptation and pathogenesis of some
bacteria (Sicard et al., 2017). Some authors also have
described stimulation of mucin productions by molec-
ular patterns such as lipopolysaccharide (Petersson et
al., 2011) relating mucin production and inflammation.
Taking all this in consideration is therefore simplistic
to draw conclusions just from an observed increase in
GC.
Our results show that inclusion of the Muramidase
007 increased ileal apparent digestibility of fat (TFA,
SFA (P = 0.08), MUFA and PUFA), particularly at
day 9 suggesting an early development of intestinal ca-
pacity to digest fat nutrient. Accordingly, plasma levels
of vitamin A also were increased at day 9 with Mu-
ramidase 007, being another indication of a better di-
gestion and absorption of fats. In poultry, the jejunum
is the major site of digestion and absorption of fat, with
the digestion continuing in the upper ileum (Ravindran
et al., 2016). It has been proposed that he immature
digestive system of young chickens could lead to the
misuse of nutrients (Kaczmarek et al., 2014) and par-
ticularly at first ages when chickens show an impaired
digestion of fat. According to Kussaibati et al. (1982),
the intestinal microbiota would be responsible for the
decreased apparent fecal digestibility of vegetable lipids
in chickens younger than 3 wk. This reduction in fat
digestibility would be the result of the deconjugation
of the bile salts by certain bacterial species, in partic-
ular lactobacilli. Since the conjugated bile salts serve
for the formation of micelles, their low concentration
would reduce lipid solubilization and thus their absorp-
tion, in particular those containing long chain satu-
rated fatty acids (Gabriel et al., 2005). In this regard,
the analysis of the cecal structure by the 16S rRNA
gene sequencing revealed important structural changes
in the microbiota between days 9 and 36 with signifi-
cant increases with age in the members of Bacteroides
genus.
Effects on Intestinal Architecture and
Immune Response
As we have seen before, improvements in AID of nu-
trients were not related to changes in intestinal his-
tomorphometry in terms of villus: crypt ratio. How-
ever, significant changes in the number of GC and IEL
were found with supplementation of Muramidase 007
at day 36 that could reflect an intestinal response con-
ditioned to differential luminal stimuli. Changes in the
microbiota, or an increase in PGNs from a higher bac-
terial turnover, or other metabolites, could be behind
these effects. Lichtenberg et al. (2017) showed higher
number of Lactobacillus in the ceca of the broilers
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supplemented with Muramidase 007 compared to the
un-supplemented broilers. In the present study, we were
unable to demonstrate quantitative changes in lacto-
bacilli or enterobacteria by plate counts among treat-
ments. However, analysis by 16S rRNA gene sequenc-
ing showed a decrease in alpha diversity at day 9 and
also an increase in the relative abundance of sequences
from the Lactobacillus genus supplementing Murami-
dase 007. Therefore, it cannot be discarded that some
changes in minor microbial groups or in microbiota
structure could have induced those changes in the local
immune response.
Changes promoted in IEL numbers were quantita-
tively low, being within the physiological range and
could reflect an activation of the intestinal mucosal
immune response of the animals without inducing
inflammation. IEL are considered part of the gut-
associated lymphoid tissue and provide a first line
of defense against intestinal microbial invasion. These
frontline lymphocytes residing within the epithelial
layer are incredibly heterogeneous regarding their func-
tion and phenotype. IEL subsets can provide immune
surveillance at the epithelial barrier to prevent or im-
pair infection in the intestine either through innate-
like mechanisms or as antigen-specific effectors or
memory CD8αβ+ T cells. However, we are only re-
cently starting to unravel the complex and sophis-
ticated network of mucosal immune responses and
function and regulation of these cells (Sheridan and
Lefrançois, 2011).
Similarly, goblet cells contribute to the protection of
the intestinal epithelium by the production and main-
tenance of the protective mucus blanket by synthesiz-
ing and secreting high-molecular-weight glycoproteins
known as mucins. Changes in GC functions and in the
chemical composition of intestinal mucus have been de-
scribed in response to a broad range of luminal insults,
including alterations of the normal microbiota (Mon-
tagne et al., 2004; Sicard et al., 2017). Available data
indicate that intestinal microbes may affect GC dy-
namics and the mucus layer directly via the local re-
lease of bioactive factors or indirectly via activation
of host immune cells (Deplancke and Gaskins, 2001).
Changes promoted by Muramidase 007, directly or in-
directly, in intestinal ecosystem or in the release of
bioactive factors could therefore be behind the observed
effects.
Effects on Gastrointestinal Microbial
groups and Cecal Fermentation
Firmicutes and Bacteroidetes were the two main bac-
terial phyla in the cecum of broilers representing more
than 80% of total sequencing. These values are in ac-
cordance to values described by other authors using 16S
rRNA gene sequencing methodology (Kers et al., 2018).
Changes observed with the age of the animals are,
however, contradictory to some previous results.
Whereas variation between individuals has been consid-
ered to decrease with the age of the animals (Crhanova
et al., 2011), in the present study we found an increase
of beta diversity with the age of animals accordingly to
what has been described by other authors (Ballou et al.,
2016). Nevertheless, dynamics and structure of intesti-
nal microbiota is not only affected by age but also by
other factors like diet, housing, litter, or climate (Kers
et al., 2018).
Including exogenous muramidase into chicken diets,
depending on dose and specificity, could have an im-
pact on the intestinal microbiota considering that in the
gut, natural endogenous muramidase is part of the pri-
mary protective factors in epithelial secretions (Harder
et al., 2007; Dave et al., 2016). HEWL is more effec-
tive against gram positive bacteria, but also has been
demonstrated to kill gram negative bacteria in vitro
(Masschalck and Michiels, 2003). In vitro experiments
with transgenic human lysozyme have shown activ-
ity against several gastrointestinal pathogens, including
Clostridium perfringens (Brundige et al., 2008). Liu et
al. (2010) showed that the administration of HEWL
in broiler diets reduced C. perfringens, Escherichia coli
and lactobacilli populations in ileal digesta of birds with
and/or without and C. perfringens challenge. In the
current study, the plate count results for Lactobacillus
and enterobacteria did not show a significant difference
with the inclusion of the microbial muramidase, in any,
crop, ileum or cecum samples. However, a statistical
trend for a decrease was observed for Clostridium in
the ileum (P = 0.06) at day 9, suggesting a possible
impact of the additive in the microbiota structure at
early age, reducing the growth of this particular mi-
crobial group. Moreover, the 16 rRNA gene sequencing
also was able to show that at day 9 animals receiving
Muramidase 007 showed lower alpha diversity although
we were not able to detect changes in particular taxo-
nomic groups. Nevertheless, such variations were small
and could be the indirect consequence of the modifi-
cation of the microenvironment in the GI tract by the
hydrolysis products of the muramidase activity or by
indirect effects associated to the increased digestibility
of nutrients.
Differences between results of these studies could be
explained by the different types (origin) of the murami-
dases evaluated: HEWL, microbial, etc., with different
properties in vitro and in vivo.
In summary, results of this study demonstrate the
positive effects of the inclusion of Muramidase 007
in the diet of broiler chickens resulting in increased
feed efficiency and improved FCR. This improvement
can be explained by a significant improvement in
the ileal digestibility of energy and nutrients. Effects
on cecal microbiota and their metabolisms seems to
be minimal, despite this some changes could be de-
tected in particular microbial genera, like an increase
in Lactobacillus. Additional studies might bring a bet-
ter understanding of the mechanisms underlying these
effects.
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